de
en
Company
Services
Mergers & Acquisitions
Equity Financing
Debt Advisory
Sectors
Health Care
Industrials & Robotics
TMT
Business Services
Consumer
Transactions
Team
Insights
News
Career
Contact
Cowen advises Gilead Sciences, Inc. on the sale of Spleen Tyrosine Kinase (SYK) Inhibitor Portfolio to Kronos Bio
Overview
July 2020
Similar Transactions